HRP20040456A2 - Stents - Google Patents

Stents Download PDF

Info

Publication number
HRP20040456A2
HRP20040456A2 HR20040456A HRP20040456A HRP20040456A2 HR P20040456 A2 HRP20040456 A2 HR P20040456A2 HR 20040456 A HR20040456 A HR 20040456A HR P20040456 A HRP20040456 A HR P20040456A HR P20040456 A2 HRP20040456 A2 HR P20040456A2
Authority
HR
Croatia
Prior art keywords
stents
formula
compounds
residue
treatment
Prior art date
Application number
HR20040456A
Other languages
English (en)
Croatian (hr)
Inventor
Perzborn Elisabeth
Kalbe Jochen
Ledwoch Wolfram
Meulien Didier
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of HRP20040456A2 publication Critical patent/HRP20040456A2/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/04—Use of organic materials, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20040456A 2001-10-24 2002-10-11 Stents HRP20040456A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10152460A DE10152460A1 (de) 2001-10-24 2001-10-24 Stents
PCT/EP2002/011402 WO2003035133A1 (de) 2001-10-24 2002-10-11 Stents

Publications (1)

Publication Number Publication Date
HRP20040456A2 true HRP20040456A2 (en) 2005-06-30

Family

ID=7703557

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040456A HRP20040456A2 (en) 2001-10-24 2002-10-11 Stents

Country Status (22)

Country Link
US (1) US20050064006A1 (enExample)
EP (1) EP1439869A1 (enExample)
JP (1) JP2005506151A (enExample)
KR (1) KR20040074977A (enExample)
CN (1) CN1575189A (enExample)
AU (1) AU2002340549B2 (enExample)
BR (1) BR0213481A (enExample)
CA (1) CA2464290A1 (enExample)
DE (1) DE10152460A1 (enExample)
EC (1) ECSP045075A (enExample)
EE (1) EE200400080A (enExample)
HR (1) HRP20040456A2 (enExample)
HU (1) HUP0401760A3 (enExample)
IL (1) IL161445A0 (enExample)
MA (1) MA26341A1 (enExample)
MX (1) MXPA04003755A (enExample)
NO (1) NO20041984L (enExample)
NZ (1) NZ532443A (enExample)
PL (1) PL367968A1 (enExample)
RU (1) RU2004115757A (enExample)
WO (1) WO2003035133A1 (enExample)
ZA (1) ZA200402989B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) * 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
PT1934208E (pt) 2005-10-04 2011-06-01 Bayer Schering Pharma Ag Nova forma polimorfa de 5-cloro-n-({(5s)-2-oxo-3-[4-(3- oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2- tiofenocarboxamida
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
US20070097252A1 (en) * 2005-10-31 2007-05-03 Silverstein D A Imaging methods, cameras, projectors, and articles of manufacture
DE102006034916A1 (de) * 2006-07-28 2008-01-31 Bayer Healthcare Ag Beschichtung künstlicher Oberflächen von medizinischen Hilfsmitteln und Geräten sowie Reinigung und/oder Vorbehandlung von Kathetern und anderen medizinischen Hilfsmitteln und Geräten
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
EP2220079A2 (en) * 2007-11-15 2010-08-25 Boehringer Ingelheim International GmbH Substituted amides, manufacturing and use thereof as medicaments
JP2023527328A (ja) * 2020-05-26 2023-06-28 エリクシアー メディカル コーポレイション 抗凝固化合物ならびにその使用のための方法およびデバイス
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2134870T3 (es) * 1993-05-01 1999-10-16 Merck Patent Gmbh Antagonistas del receptor de adhesion.
US6133256A (en) * 1997-04-14 2000-10-17 Cor Therapeutics Inc Selective factor Xa inhibitors
US6273913B1 (en) * 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US20010029351A1 (en) * 1998-04-16 2001-10-11 Robert Falotico Drug combinations and delivery devices for the prevention and treatment of vascular disease
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10105989A1 (de) * 2001-02-09 2002-08-14 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung

Also Published As

Publication number Publication date
EP1439869A1 (de) 2004-07-28
NZ532443A (en) 2005-11-25
KR20040074977A (ko) 2004-08-26
NO20041984L (no) 2004-05-13
EE200400080A (et) 2004-08-16
IL161445A0 (en) 2004-09-27
DE10152460A1 (de) 2003-05-08
BR0213481A (pt) 2004-11-03
US20050064006A1 (en) 2005-03-24
RU2004115757A (ru) 2005-04-10
ZA200402989B (en) 2005-04-20
JP2005506151A (ja) 2005-03-03
HUP0401760A3 (en) 2008-04-28
MXPA04003755A (es) 2004-07-23
ECSP045075A (es) 2004-05-28
WO2003035133A1 (de) 2003-05-01
AU2002340549B2 (en) 2007-11-29
PL367968A1 (en) 2005-03-07
CN1575189A (zh) 2005-02-02
MA26341A1 (fr) 2004-10-01
HUP0401760A2 (hu) 2004-12-28
CA2464290A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
HRP20040456A2 (en) Stents
JP4757448B2 (ja) 医療用装置塗布方法
JP4473390B2 (ja) ステント及びステントグラフト
US7887871B2 (en) Method and system for irradiation of a drug eluting implantable medical device
Yoshida et al. Surface modification of polymers by plasma treatments for the enhancement of biocompatibility and controlled drug release
JP4549059B2 (ja) 再狭窄を防止するためのステントのコーテイング
US10029034B2 (en) Drug-eluting articles with improved drug release profiles
CA2607413C (en) Coating of the entire surface of endoprostheses
CN101795719A (zh) 药物缓释性支架
US20050043788A1 (en) Drug-eluting stent
US20040171589A1 (en) Differential delivery of nitric oxide
CN101370448A (zh) 血管支架及其制造方法
JP2011514231A (ja) 生分解性炭素ジアゼニウムジオレート系酸化窒素供与重合体
JP2005199079A (ja) 血管内ステントを製造する方法、及びこの方法で製造されたステント
JP2009540873A (ja) マルチコンポーネント型繊維を備えた医用デバイス
PT1192957E (pt) Revestimento para dispositivos médicos
WO2003022323A1 (en) Coating for reducing the rate of release of drugs from stents
NZ546068A (en) Biocompatible, biostable coating of medical surfaces
WO2014125465A2 (en) Method for loading dilatable catherer balloons and dilatation catheters obtained therefrom
EP1781203B1 (en) Methods and systems for loading an implantable medical device with beneficial agent
OA13261A (en) Biocompatible, biostable coating of medical surfaces.
CN101522229A (zh) 医学辅助器具和设备的人工表面的涂覆以及净化和/或预处理导管和其它医学辅助器具和设备
Lyu et al. Drug–Material Interactions, Materials Selection, and Manufacturing Methods
US20040236413A1 (en) Stents with vitronectin receptor antagonists against restenosis
PL236142B1 (pl) Sposób wytwarzania z układu kopolimer-inhibitor szlaku mTOR powłoki o kontrolowanej kinetyce uwalniania inhibitora szlaku mTOR na polimerowych stentach naczyniowych

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20081010

Year of fee payment: 7

OBST Application withdrawn